Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ETROLIZUMAB1件: Etrolizumab (Etrolizumab)1件: Etrolizumab (Etrolizumab) 💬 1件: ITGB7 💬 13件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Integrin signaling, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer 💬2件: 96, 97 💬
2EtrolizumabProduct Code: RO5490261/F04-02Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: EtrolizumabCAS Number: 1044758-60-2Current Sponsor code: RO5490261Other descriptive name: rhuMAb Beta7, Anti Beta7, PRO145223Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 105-----1件: 97 💬